Sort
23,748 grants matching “melanoma”
SOUTHWEST ONCOLOGY GROUP STUDY
$135,894Case Western Reserve University · U10 · FY2002 · CA
SOUTHWEST ONCOLOGY GROUP STUDIES
$135,861University Of Kansas Medical Center · U10 · FY2003 · CA
Hypoxia inducible transcription in antitumor strategies
$135,837Dana-Farber Cancer Institute · K01 · FY2001 · CA
St.Louis-Cape Girardeau CCOP
$135,806St.Louis-Cape Girardeau Ccop · U10 · FY2003 · CA
Expanding the Therapeutic Window of Nanoparticle STING Agonists for Cancer Immunotherapy
$135,806John Tanner Wilson · Vanderbilt University · R01 · FY2021 · CA
Identifying New SNPs in miRNAs and their Role in Predicting Breast Cancer Risk
$135,695Sharmila Manjeshwar · Intergenetics Incorporated · R43 · FY2007 · CA
Biostatistics and Bioinformatics Core
$135,637Donald A Berry · University Of Tx Md Anderson Can Ctr · P50 · FY2011 · CA
Administrative Core
$135,630Jessie Villanueva · Wistar Institute · U54 · FY2025 · CA
Clinical development of a blood based assay that detects the BRAF V600E mutation in melanoma and thyroid cancer patients
$135,613Ryan J Sullivan · Massachusetts General Hospital · UH2 · FY2019 · CA
Mechanism-based strategies to target oncogenic BRAF signaling
$135,600Poulikos I Poulikakos · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · CA
Core E: Biostatistics Core
$135,553Meenhard Herlyn · Wistar Institute · P01 · FY2013 · CA
Dendritic Cell-Based Genetic Immunotherapy for Melanoma
$135,543University Of California Los Angeles · R01 · FY2005 · CA
Sun Exposure and Melanoma in Agricultural Workers
$135,513University Of Iowa · K07 · FY2005 · CA
Research and Mentoring on Energetic Factors and Cancer: Established Investigator
$135,505Leslie Bernstein · Beckman Research Institute/City Of Hope · K05 · FY2010 · CA
Clinical Investigation in Tumor Immunotherapy
$135,488Jeffrey A Sosman · Vanderbilt University · K24 · FY2006 · CA
ANALYSIS OF BMT CONDITIONING, CYTOKINES, GVHD AND GVL
$135,290Dana-Farber Cancer Institute · P01 · FY2002 · CA
TUMOR VACCINES AND BONE MARROW TRANSPLANTATION
$135,290Dana-Farber Cancer Institute · P01 · FY2002 · CA
TUMOR VACCINES AND BONE MARROW TRANSPLANTATION
$135,290Dana-Farber Cancer Institute · P01 · FY2001 · CA
ANALYSIS OF BMT CONDITIONING, CYTOKINES, GVHD AND GVL
$135,290Dana-Farber Cancer Institute · P01 · FY2001 · CA
The role of endothelial to mesenchymal transition (EndMT) in the tumor stroma
$135,270Elisabeth M Zeisberg · Beth Israel Deaconess Medical Center · K08 · FY2011 · CA
The role of endothelial to mesenchymal transition (EndMT) in the tumor stroma
$135,270Elisabeth M Zeisberg · Beth Israel Deaconess Medical Center · K08 · FY2010 · CA
The role of endothelial to mesenchymal transition (EndMT) in the tumor stroma
$135,270Elisabeth M Zeisberg · Beth Israel Deaconess Medical Center · K08 · FY2009 · CA
The role of endothelial to mesenchymal transition (EndMT) in the tumor stroma
$135,270Elisabeth M Zeisberg · Beth Israel Deaconess Medical Center · K08 · FY2008 · CA
CYSTATIN C EFFECT ON B16 MELANOMA METASTASIS
$135,224A.T. Still University Of Health Sciences · R01 · FY2000 · CA
Core--Clinical
$135,204Joseph Wayne Fay · Baylor Research Institute · P01 · FY2008 · CA